BLOG
Navigating the Prescription Drug Reform Act: A New Landscape for Drug Manufacturers in Florida
Navigating the Prescription Drug Reform Act: A New Landscape for Drug Manufacturers in Florida | by: Kelly DiBattista, Esq., Research Director | Article Posted: July 5, 2023 | Introduction of FL S1550 On May 4, 2023, Florida introduced new drug price transparency...
Recent Articles
Emergency Use Authorization Policy Ending for EUA Medical Devices
Emergency Use Authorization Policy Ending for EAU Medical Devices Written-by: Sumeet Singh, CEO FDA To Host Webinar to Establish Transition...
DSCSA Final Proposal Rules Submitted to OMB
DSCSA Final Proposal Rules Submitted to OMB Is 2022 the year for FDA to release Proposed Rules for the National Standards for the Licensure of...
5 Changes to be Implemented by DEA
Changes to be Implemented by DEA The opioid epidemic has had widespread social and economic impact, and legislation is finally catching up. The...
Oregon Passes Pharmaceutical Representative Licensure & Disclosure Law, Effective January 1, 2022
A PBM audit often invokes a great sense of dread by all the pharmacy’s employees but especially for the pharmacy owner. In 2020, the average PBM...
Top 5 Mistakes Pharmacies Make During URAC Accreditation
A PBM audit often invokes a great sense of dread by all the pharmacy’s employees but especially for the pharmacy owner. In 2020, the average PBM...
The Increasing Trend of Drug Price Transparency
A PBM audit often invokes a great sense of dread by all the pharmacy’s employees but especially for the pharmacy owner. In 2020, the average PBM...
